GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » YoY Rev. per Sh. Growth

Curatis Holding AG (XSWX:CURN) YoY Rev. per Sh. Growth : 0.00% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Curatis Holding AG's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 was 0.00%.

Curatis Holding AG's Revenue per Share for the six months ended in Jun. 2024 was CHF0.45.

Curatis Holding AG YoY Rev. per Sh. Growth Historical Data

The historical data trend for Curatis Holding AG's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG YoY Rev. per Sh. Growth Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
- - -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - - - -

Curatis Holding AG YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Curatis Holding AG's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0-0)/ | 0 |
=N/A %

Curatis Holding AG's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Jun. 2024 )
=(Revenue per Share (Q: Jun. 2024 )-Revenue per Share (Q: Jun. 2023 )) / | Revenue per Share (Q: Jun. 2023 )) |
=(0.451-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM BOM:500124 NBIX BOM:543904 BOM:532321
Traded in Other Exchanges
CURNz:UK 26U:Germany
Address
Weierweg 7, Liestal, CHE, CH-4410
Website
https://www.curatis.com
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.